Yu-Hsuan Li Selected Research

Yu-Hsuan Li Research Topics

Disease

8	Neoplasms (Cancer) 07/2023 - 07/2014
4	Type 2 Diabetes Mellitus (MODY) 03/2023 - 01/2018
3	Lung Neoplasms (Lung Cancer) 11/2023 - 01/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 10/2020
3	Coronary Artery Disease (Coronary Atherosclerosis) 07/2022 - 01/2018
2	Carcinogenesis 11/2023 - 01/2020
2	Mouth Neoplasms (Oral Cancer) 01/2020 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2019
2	Chronic Renal Insufficiency 01/2018 - 01/2018
1	Metabolic Diseases (Metabolic Disease) 04/2024
1	Pre-Eclampsia (Preeclampsia) 04/2024
1	Obesity 04/2024
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023
1	COVID-19 03/2023
1	Prediabetic State (Prediabetes) 07/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Abdominal Pain (Pain, Abdominal) 01/2022
1	Diarrhea 01/2022
1	Tuberculosis (Tuberculoses) 09/2021
1	Diabetes Mellitus 09/2021
1	Infections 09/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2021
1	Graves Disease (Basedow Disease) 10/2020
1	Hyperthyroidism 10/2020
1	Disease Progression 10/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Tongue Neoplasms (Tongue Neoplasm) 01/2020
1	Fibrosis (Cirrhosis) 01/2019
1	Airway Obstruction (Choking) 01/2019
1	Tracheomalacia 01/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2018
1	Multiple Myeloma 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2016
1	Hepatocellular Carcinoma (Hepatoma) 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 07/2014
1	Inflammation (Inflammations) 07/2013

Drug/Important Bio-Agent (IBA)

4	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 01/2018
2	Metformin (Glucophage)FDA LinkGeneric 04/2024 - 09/2021
2	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2020
2	AntigensIBA 07/2023 - 01/2020
2	LigandsIBA 07/2023 - 01/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 12/2018
2	Histone Deacetylase 6IBA 01/2018 - 01/2018
2	Histone Deacetylase InhibitorsIBA 01/2016 - 07/2014
1	Tyrosine Kinase InhibitorsIBA 11/2023
1	Gefitinib (Iressa)FDA Link 11/2023
1	Receptor for Advanced Glycation End ProductsIBA 11/2023
1	ErbB Receptors (EGF Receptor)IBA 11/2023
1	Immune Checkpoint InhibitorsIBA 07/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 07/2023
1	Pemetrexed (MTA)FDA Link 07/2023
1	HLA-G Antigens (HLA G)IBA 07/2023
1	Immune Checkpoint ProteinsIBA 07/2023
1	AndrogensIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	Insulin (Novolin)FDA Link 09/2021
1	Retinaldehyde (Retinal)IBA 03/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Antithyroid Agents (Antithyroid Drugs)IBA 10/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2020
1	Antineoplastic Agents (Antineoplastics)IBA 10/2020
1	CarbohydratesIBA 01/2020
1	Histone DemethylasesIBA 01/2020
1	Silybin (Lagosa)IBA 01/2020
1	Carcinoembryonic AntigenIBA 01/2020
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2019
1	Arecoline (Arecolin)IBA 01/2019
1	AlkaloidsIBA 01/2019
1	Death Domain ReceptorsIBA 12/2018
1	EscinIBA 12/2018
1	Cytochromes c (Cytochrome c)IBA 12/2018
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 12/2018
1	LDL CholesterolIBA 11/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2018
1	oxidized low density lipoproteinIBA 11/2018
1	Staphylococcal Protein A (Protein A)IBA 01/2018
1	renalaseIBA 01/2018
1	Bortezomib (Velcade)FDA Link 01/2018
1	Endothelin-1 (Endothelin 1)IBA 01/2018
1	AlbuminsIBA 01/2018
1	QuinolinesIBA 01/2018
1	CholesterolIBA 03/2016
1	3- (1- (4- methoxybenzenesulfonyl)- 2,3- dihydro- 1H- indol- 5- yl)- N- hydroxyacrylamideIBA 01/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	Histones (Histone)IBA 07/2014
1	Protein Kinase CIBA 07/2014
1	Cadherins (E-Cadherin)IBA 07/2014
1	CarrageenanIBA 07/2013

Therapy/Procedure

4	Therapeutics 09/2021 - 07/2014
1	Drug Therapy (Chemotherapy) 07/2023
1	Glycemic Control 03/2023
1	Stents 01/2019